Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Locomotion in young rats with induced brain cellular edema - effects of recombinant human erythropoietin

D. Maresova, P. Kozler, E. Miletínová, T. Zima, J. Pokorny,

. 2018 ; 39 (4) : 310-314.

Jazyk angličtina Země Švédsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012060

OBJECTIVES: Effect of recombinant human erythropoietin (rhEPO) on spontaneous motor activity was tested in young rats after intraperitoneal (i.p.) administration of rhEPO, followed by induction of cellular brain edema (CE). Induced changes in the spontaneous horizontal locomotor activity was studied by open field test (OFT). METHODS: CE was induced by water intoxication (WI) using standard method of fractional hyperhydration accompanied with desmopressin administration. Using the accepted method of OFT average time spent in locomotion (s) was determined. 48 young rats at the age of 25, and 35 days were divided into three groups - controls, rats after WI (OFT followed after 44 hours), and rats administered with rhEPO prior to application WI (OFT after 48 hours). RESULTS: In 35-day-old rats rhEPO administration increased the spontaneous locomotor activity, previously decreased by cellular edema. In 25-day-old rats, rhEPO administration prior to the induced CE, decreased spontaneous locomotor activity. CONCLUSION: Presented results demonstrate the neuroprotective capacity of rhEPO, manifested by elimination of the suppressive influence of CE on the locomotion in 35-day-old rats. In 25-day-old rats the neuroprotective effect was not present. These results confirmed that the 10 day interval in the development may represent a different stage of brain maturation in the relation to the neuroprotective effect of rhEPO.

000      
00000naa a2200000 a 4500
001      
bmc19012060
003      
CZ-PrNML
005      
20190405112111.0
007      
ta
008      
190405s2018 sw f 000 0|eng||
009      
AR
035    __
$a (PubMed)30531705
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Maresova, Dana $u Institute of Physiology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
245    10
$a Locomotion in young rats with induced brain cellular edema - effects of recombinant human erythropoietin / $c D. Maresova, P. Kozler, E. Miletínová, T. Zima, J. Pokorny,
520    9_
$a OBJECTIVES: Effect of recombinant human erythropoietin (rhEPO) on spontaneous motor activity was tested in young rats after intraperitoneal (i.p.) administration of rhEPO, followed by induction of cellular brain edema (CE). Induced changes in the spontaneous horizontal locomotor activity was studied by open field test (OFT). METHODS: CE was induced by water intoxication (WI) using standard method of fractional hyperhydration accompanied with desmopressin administration. Using the accepted method of OFT average time spent in locomotion (s) was determined. 48 young rats at the age of 25, and 35 days were divided into three groups - controls, rats after WI (OFT followed after 44 hours), and rats administered with rhEPO prior to application WI (OFT after 48 hours). RESULTS: In 35-day-old rats rhEPO administration increased the spontaneous locomotor activity, previously decreased by cellular edema. In 25-day-old rats, rhEPO administration prior to the induced CE, decreased spontaneous locomotor activity. CONCLUSION: Presented results demonstrate the neuroprotective capacity of rhEPO, manifested by elimination of the suppressive influence of CE on the locomotion in 35-day-old rats. In 25-day-old rats the neuroprotective effect was not present. These results confirmed that the 10 day interval in the development may represent a different stage of brain maturation in the relation to the neuroprotective effect of rhEPO.
650    _2
$a věkové faktory $7 D000367
650    _2
$a zvířata $7 D000818
650    _2
$a chování zvířat $x účinky léků $7 D001522
650    _2
$a edém mozku $x patofyziologie $7 D001929
650    _2
$a erythropoetin $x farmakologie $7 D004921
650    _2
$a lokomoce $x účinky léků $7 D008124
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a pohybová aktivita $x účinky léků $7 D009043
650    _2
$a neuroprotektivní látky $x farmakologie $7 D018696
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a rekombinantní proteiny $x farmakologie $7 D011994
650    _2
$a intoxikace vodou $x patofyziologie $7 D014869
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kozler, Petr $u Institute of Physiology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Miletínová, Eva $u National Institute of Mental Health, Czech Republic.
700    1_
$a Zima, Tomas $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Pokorny, Jaroslav $u Institute of Physiology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 39, č. 4 (2018), s. 310-314
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30531705 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190405112120 $b ABA008
999    __
$a ok $b bmc $g 1391370 $s 1050365
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 39 $c 4 $d 310-314 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...